Epidermolysis Bullosa Acquisita Responsive to Dapsone Therapy
2001 ◽
Vol 5
(5)
◽
pp. 397-399
◽
Keyword(s):
Background: Epidermolysis bullosa acquisita (EBA) is a chronic subepidermal blistering disease that is frequently resistant to therapy. Objective: A 58-year-old man who had a one-year history of a bullous eruption involving the hands, forearms, trunk, scalp, and oral mucosa. Histopathology revealed a subepidermal bulla, and direct and indirect immunofluorescence studies were consistent with EBA. The patient failed respond to niacinamide and tetracycline and oral prednisone 40 mg per day. Methods: Complete control of his blistering was achieved within two months of initiating oral dapsone, 150 mg per day. Conclusion: Dapsone may be an effective agent for some patients with EBA.
1985 ◽
Vol 84
(6)
◽
pp. 472-476
◽
1990 ◽
Vol 22
(4)
◽
pp. 664-670
◽
2016 ◽
Vol 17
(7)
◽
pp. 1116
◽
Keyword(s):
2018 ◽
Vol 22
(3)
◽
pp. 356-358
◽
Keyword(s):